Nick Wilson

Biography
Nick is the Head of the Immunology Research Unit at Biogen, where he leads strategic efforts to advance innovative research and develop transformative therapies in immunology. Prior to this role, Nick served as the Head of Discovery Cancer Immunology and Cell Therapy at Bristol Myers Squibb. With a career spanning multiple leading biotechnology companies, Nick has held key positions at Gilead, Novartis, Agenus, Merck KGaA, and CSL Limited across California, Massachusetts, and Australia. As a trained immunologist, Nick is deeply committed to leveraging causal biology to prioritize drug discovery targets and driving efficient clinical decision-making by evaluating pharmacologic endpoints predictive of clinical benefit.